Over the past year, the "digital" development model pioneered by NuMedii has begun to deliver, with a Phase IIa trial of a computationally found drug-disease match now underway. The next clinical candidates are in databases awaiting discovery, and this week NuMedii inked a deal to increase its chances of finding them.
NextBio was set up to solve a problem partly created by Illumina's success in next-generation sequencing--how to make Big Data accessible and useful to researchers. Now, Illumina is to offer its own solution by acquiring NextBio and combining it with its BaseSpace cloud computing environment.
Deloitte has moved quickly to tap into the wealth of electronic health records (EHRs) that form the bedrock of the 5-year alliance it formed with Intermountain Health in February. Having unveiled the first fruit of the collaboration in June, Deloitte introduced its second product this week.
The rise of complex data-crunching techniques and software has put powerful statistical approaches into the hands of more scientists. While this has democratized the ability to probe information for insights, it has also increased the risk scientists will misuse statistics and find false positives. Statisticians are worried.
Having updated its disease-modeling platform last week, tech giant IBM has now snagged a grant to dig into electronic health records to predict heart disease and opened a Big Data research lab.
The rise of electronic health records (EHRs) is cutting the time it takes to spot changes in incidence of disease, but without context it is hard to see what is driving the shifts. A Big Data analytics platform from IBM, Johns Hopkins University and University of California is aiming to facilitate these insights.
The use of existing drugs in new therapeutic areas has a rich history, with Viagra's serendipitous pivot from anti-angina flop to erectile dysfunction blockbuster being the standout example. Bioinformatics is now taking the guesswork out of repositioning, slashing the time and money needed to reach the clinic.
When President Obama unveiled the BRAIN Initiative in April, his speech was heavy on lofty rhetoric but light on detail. This week the team tasked with turning the grand vision into practical projects filed its first report, and placed strong emphasis on improving data storage, analysis and interpretation.
The term "Big Data" sounds mostly like marketing speak to real data scientists, who work with datasets of all sizes to develop applications in healthcare and other sectors. For these data pros, it's about having the right data, not just a lot of data, to make sure they are providing something of value to a customer. Secure a seat now.
Big Pharma and academic groups have made more progress in joining forces on advancing software for translational research on a pre-competitive basis.